SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks
Pharmos(PARS)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
1491 8 0 PARS
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1466 Congrats on that trade, Rick! I just hope something like that doesn't hapAriella-10/26/1998
1465 Dr. Lester Grinspoon of Harvard posted part of my note in his website about medAriella-10/26/1998
1464 Ariella, The WSJ article about consolidation in the biotech sector proved to beRick Strange-10/26/1998
1463 To all: I don't know if any on this thread track short interest but if youJohn Goodman-10/25/1998
1462 All you doctors put your thinking caps on: sciweb.com Describes patent grantedAriella-10/24/1998
1461 Bio tech sector is about to have its day. And Pharmos is about to get into + cayosi s-10/23/1998
1460 Just a Note- Mierav Kohav the Smith Barney Analysts is an Israeli familiar witDavid Israel-Rosen-10/23/1998
1459 Another interesting read is in this morning's Wall Street Journal. <<Ariella-10/23/1998
1458 Excellent article, Rick. Thought provoking. -Ariella (eom) Ariella-10/23/1998
1457 An interesting read. "Lifeless Sciences: What's Ailing The Biotechs&quRick Strange-10/23/1998
1456 199<b>9</b> for Q3 results, Richard? Wow! I think I'd rather tAriella-10/21/1998
1455 11/03/99 as published by Zacks Analyst WatchRichard Huth-10/21/1998
1454 Yosi & Ariella, maybe the next time one of us talks to the company we can aRick Strange-10/21/1998
1453 Rick, I thought the split was not 50-50 and that's why more are getting deAriella-10/20/1998
1452 NEXT STEP IS TO CROSS RESISTENCE @ 2.375 I EXPECT IT THIS WEEKDavid Israel-Rosen-10/20/1998
1451 The last cohort of the phase 2 trial is split 2:1 In a sense they haveyosi s-10/20/1998
1450 Anyone have any idea why 2/3rds of the patients in the 3rd cohort of the currenRick Strange-10/20/1998
1449 Merav...really great article. Thanks....Ariella (eom)Ariella-10/20/1998
1448 Investor chat rooms give companies fits -- that's the title of an interestiMerav-10/19/1998
1447 Dear Rick -- I think you are right. So is David's optimism. If I were a beAriella-10/19/1998
1446 There were two block trades between 10:30-11:00, one for 250K and one for 200K.Rick Strange-10/19/1998
1445 Dear Shlepper: PARS is not a marketing company. I doubt that they will do anyDavid Israel-Rosen-10/18/1998
1444 Israeli Regulatory agency will be reluctant to approve a drug that was not appryosi s-10/18/1998
1443 David, What are the chances of expedited use of HU-211 in Israel? Since thereShlepper-10/18/1998
1442 Second week of NovemberDavid Israel-Rosen-10/18/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News